United States · FDA National Drug Code directory

TENIVAC

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
49281-215_737f89ae-a592-44db-94a4-8a4524ee027f
Product NDC
49281-215
Form
INJECTION, SUSPENSION
Composition / generic term
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Labeler
Sanofi Vaccines US Inc.
Marketing category
BLA
Marketing start / end (source format)
20101208
Source listing expiry
20271231

Source-listed ingredients

  • CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) — 5 [Lf]/.5mL
  • CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) — 2 [Lf]/.5mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 VIAL, SINGLE-DOSE in 1 PACKAGE (49281-215-10) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-215-58) · 49281-215-10
  • 10 SYRINGE in 1 PACKAGE (49281-215-15) / .5 mL in 1 SYRINGE (49281-215-88) · 49281-215-15

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →